MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Stock Quote
- Sector Info (List of ipharm Stocks)
- Ipharm Stocks
Ipharm
Stocks 
Here are the latest stock price details of the top stocks in the Ipharm Group. For more detailed updates, check the latest Ipharm Group results.
Revealed: 3 Stocks for Potentially Massive Gains
| SCRIP | BSE PRICE (Rs) | NSE PRICE (Rs) | CHART | MORE INFO |
|---|---|---|---|---|
| AARTI DRUGS | 696.00 -5.15% | 695.85 -5.13% |
|
More Info
|
| AJANTA PHARMA | 1,705.00 -1.31% | 1,699.00 -1.73% |
|
More Info
|
| ALEMBIC PHARMA | 966.00 -4.42% | 964.50 -4.88% |
|
More Info
|
| BIOCON | 405.15 -3.60% | 405.40 -3.55% |
|
More Info
|
| CADILA HEALTHCARE | 505.70 -1.72% | 505.20 -1.80% |
|
More Info
|
| CIPLA | 907.50 2.86% | 908.00 2.83% |
|
More Info
|
| DIVIS LABORATORIES | 3,800.00 1.30% | 3,795.00 1.14% |
|
More Info
|
| DR. REDDYS LAB | 5,094.80 7.04% | 5,095.00 7.03% |
|
More Info
|
| GLENMARK PHARMA | 503.40 -4.95% | 502.85 -5.06% |
|
More Info
|
| INDOCO REMEDIES | 300.05 -5.11% | 305.00 -3.83% |
|
More Info
|
| IPCA LABS | 2,159.15 3.55% | 2,150.00 3.07% |
|
More Info
|
| J.B.CHEMICALS | 1,228.00 -2.16% | 1,219.75 -2.71% |
|
More Info
|
| LUPIN | 1,053.60 -2.41% | 1,048.00 -2.91% |
|
More Info
|
| NATCO PHARMA | 919.60 -0.23% | 918.80 -0.34% |
|
More Info
|
| NIFTY 50 | Not Listed | 14,349.60 -3.27% |
|
More Info
|
| ORCHID PHARMA | 1,902.80 -5.00% | 18.90 -2.83% |
|
More Info
|
| PANACEA BIOTECH | 280.10 19.98% | 280.10 19.98% |
|
More Info
|
| PIRAMAL ENTERPRISES | 1,642.75 -9.22% | 1,637.00 -9.52% |
|
More Info
|
| S&P BSE SENSEX | 47,883.38 -3.44% | Not Listed |
|
More Info
|
| STRIDES PHARMA SCIENCE | 880.00 1.99% | 879.00 1.88% |
|
More Info
|
| SUN PHARMA | 622.80 -2.22% | 622.45 -2.25% |
|
More Info
|
| TORRENT PHARMA | 2,579.15 0.22% | 2,570.00 -0.18% |
|
More Info
|
| WOCKHARDT | 440.75 -7.12% | 440.40 -7.33% |
|
More Info
|
BSE prices: April 12, 2021 03:36:00 PM NSE prices: April 12, 2021 3:29:59 PM
Ipharm Stocks Update
Within the Ipharm sector, the top gainers were PANACEA BIOTECH (up 20.0%) and DR. REDDYS LAB (up 7.0%). On the other hand, PIRAMAL ENTERPRISES (down 9.2%) and WOCKHARDT (down 7.1%) were among the top losers.
Meanwhile, the benchmark S&P BSE SENSEX was at 47,883.4 (down 3.4%).
What else is happening in the markets today? Dig in...
- TRACK NOW:
- Most Active Stocks Rs 0 to 10
- Most Active Stocks Rs 10 to 20
- Top Gainers Today BSE A Group
- Top Gainers Today NSE Above Rs 20
- Top Gainers Today BSE Above Rs 20
- Top Gainers Today BSE Sensex
- Top Gainers Today BSE Small Cap
- Top Gainers Today BSE 500
- Top Losers Today BSE A Group
- Most Active Stocks Rs 1 to 2
- Top Losers Today NSE Above Rs 20
- Buzzing Stocks Today
- Most Popular Stocks BSE 30
- TRENDING ON EQUITYMASTER:
- Warren Buffett - The Value Investor
- Your Ultimate Guide to Penny Stock Investing
- How to Invest in Gold
- Basics of Value Investing
- Benjamin Graham
- The Best Bluechip Stocks to Buy
- How to Invest in Silver
- The Best Small-cap Stocks to Buy
- 10 Rules for Successful Long-Term Investing
- How to Invest in the Share Market
- Best Stocks to Buy Today
- How to Use P/E for Successful Investing
- How to Find Undervalued Stocks
- Differences Between Trading and Investing
- SWOT Analysis for Stocks
- The Best Dividend Stocks to Buy
Today's Market
6 Reasons Why Sensex Plunged 1,708 Points Today(Closing)
Indian share markets witnessed huge selling pressure today as fears that the government could go for stricter lockdowns.
Related Views on News
PIRAMAL ENTERPRISES Share Price Down by 10%; BSE HEALTHCARE Index Down 1.0% (Market Updates)
Apr 12, 2021 | Updated on Apr 12, 2021PIRAMAL ENTERPRISES share price is trading down by 10% and its current market price is Rs 1,790. The BSE HEALTHCARE is down by 1.0%. The top gainers in the BSE HEALTHCARE Index are DR. LAL PATHLABS (up 6.5%) and IPCA LABS (up 3.4%). The top losers is PIRAMAL ENTERPRISES (down 10.0%).
JUBILANT PHARMOVA Share Price Up by 6%; BSE HEALTHCARE Index Up 0.6% (Market Updates)
Apr 12, 2021 | Updated on Apr 12, 2021JUBILANT PHARMOVA share price is trading up by 6% and its current market price is Rs 786. The BSE HEALTHCARE is up by 0.6%. The top gainers in the BSE HEALTHCARE Index are JUBILANT PHARMOVA (up 6.2%) and IPCA LABS (up 5.3%). The top losers are GLENMARK PHARMA (down 0.1%) and ALEMBIC PHARMA (down 0.2%).
GLENMARK PHARMA Share Price Down by 7%; BSE HEALTHCARE Index Down 1.0% (Market Updates)
Apr 12, 2021 | Updated on Apr 12, 2021GLENMARK PHARMA share price is trading down by 7% and its current market price is Rs 537. The BSE HEALTHCARE is down by 1.0%. The top gainers in the BSE HEALTHCARE Index are DR. LAL PATHLABS (up 6.5%) and IPCA LABS (up 3.5%). The top losers are GLENMARK PHARMA (down 6.5%) and PIRAMAL ENTERPRISES (down 10.0%).
STRIDES PHARMA SCIENCE Share Price Down by 5%; BSE HEALTHCARE Index Down 1.6% (Market Updates)
Apr 12, 2021 | Updated on Apr 12, 2021STRIDES PHARMA SCIENCE share price is trading down by 5% and its current market price is Rs 860. The BSE HEALTHCARE is down by 1.6%. The top gainers in the BSE HEALTHCARE Index are THYROCARE TECHNOLOGIES (up 4.2%) and JUBILANT PHARMOVA (up 3.2%). The top losers are STRIDES PHARMA SCIENCE (down 4.7%) and PIRAMAL ENTERPRISES (down 5.8%).
DIVIS LABORATORIES Announces Quarterly Results (3QFY21); Net Profit Up 27.9% (Quarterly Result Update)
Feb 10, 2021 | Updated on Feb 10, 2021For the quarter ended December 2020, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 27.9% YoY). Sales on the other hand came in at Rs 17 bn (up 19.1% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.
More Views on NewsMost Popular
A Critical Update on the Market (Fast Profits Daily)
Mar 30, 2021In this video, I'll tell you why I am recommending caution in the market at this time.
My Recent Recommendation Will Profit from the Global Supply Chain Crisis (Profit Hunter)
Mar 31, 2021A tiny chemical company, started in the Licence Raj era, is a great example of a new wealth creating opportunity.
My Stock Trading Strategy (Fast Profits Daily)
Mar 31, 2021In this video I'll show you exactly how I go about picking stocks for trading.
What You Need to Find Hundred Baggers (Profit Hunter)
Mar 30, 2021100 baggers of the last decade share this common trait. Here's how to use it to nail future multibaggers.
MoreOUR TOP 5 IDEAS
- India's Revival: A Once-in-a-generation Wealth Making Opportunity
- Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
- Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
- Free Report: The Secret to Increasing Your Trading Profits Daily!
- No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.
SUN PHARMA SHARE PRICE
Apr 12, 2021 03:36 PM
TRACK SUN PHARMA
- Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
- Add To MyStocks
MORE ON SUN PHARMA
SUN PHARMA - ADCOCK INGRAM COMPARISON
COMPARE SUN PHARMA WITH
MARKET STATS
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
- Basics of Value Investing
- Benjamin Graham
- How to Invest in Gold
- How to Invest in Silver
- Best Stocks to Buy Today
- Warren Buffett - The Value Investor
- The Best Small-cap Stocks to Buy
- The Best Bluechip Stocks to Buy
- Your Ultimate Guide to Penny Stock Investing
- 10 Rules for Successful Long-Term Investing
- How to Invest in the Share Market
- Momentum Moves
FOLLOW
APP
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.